Categories: News

Edison Issues Report on Metro Bank (MTRO)

London, United Kingdom–(Newsfile Corp. – October 31, 2024) – Edison issues report on Metro Bank (LSE: MTRO).

Having successfully refinanced in late 2023, Metro Bank is making good progress with repositioning its business model towards higher-return commercial and specialist mortgage lending, reducing its cost of funding and shrinking its cost base. It confidently expects to be profitable before year-end and has guided to strong progress thereafter, reaching a mid- to upper-teens percentage return on tangible equity from 2027. Despite a strong performance since the interims, Metro’s shares are far from pricing in the scale of improvement that management is guiding towards.

Click here to read the full report.

All reports published by Edison are available to download free of charge from its website www.edisongroup.com.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

enquiries@edisongroup.com

+44 (0)20 3077 5700

Connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/
X www.x.com/edison_inv_res
YouTube www.youtube.com/edisonitv

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228464

Staff

Recent Posts

Pioneering Scientist David Deamer to receive ABRF Award for Outstanding Contributions to Biomolecular Technologies

 LEXINGTON, Ky. , Nov. 2, 2024 /PRNewswire/ -- The Association of Biomolecular Resource Facilities (ABRF) is…

2 hours ago

Optimal Breathing Holds its Annual Black Friday Sale

Turbo Oxygen EWOt System with 900 Liter Oxygen Reservoir Bag and Patented Mega-Flow Mask with…

11 hours ago

Nihon Kohden Introduces First-Ever ATO-Certified Ventilators

IRVINE, Calif.--(BUSINESS WIRE)--#RespiratoryCare--Nihon Kohden, a global leader in medical technology, today announced the introduction of…

1 day ago

2025 Medicare Physician Fee Schedule Final Rule Includes Two Major Wins for Therapy Providers

APTA advocacy leads to impactful policy wins that will reduce administrative burden, improve access, and…

1 day ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., Nov. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical…

1 day ago

Gestalt and Paige Partner to Enhance Digital Pathology Workflows with Integration of Advanced AI Algorithms

SPOKANE, Wash. and NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Gestalt, a leader in digital pathology…

1 day ago